Starch, corn is an investigational drug.
There have been 6 clinical trials for Starch, corn.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2019.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Osteoarthritis, Knee. The leading clinical trial sponsors are Mike O'Callaghan Military Hospital, Chang Gung Memorial Hospital, and Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland.
There are four hundred and eighty-nine US patents protecting this investigational drug and four international patents.